| Lastest Insider Transactions Of LIGAND PHARMACEUTICALS INC ( LGND ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| LGND | LIGAND PHARMACEUTICALS INC | Reardon Andrew | CLO & Secretary | 2024-09-23 | Sell | 2,000 | 99.60 | 199,201 | 2024-09-25 20:54:39 |
| LGND | LIGAND PHARMACEUTICALS INC | Reardon Andrew | CLO & Secretary | 2024-09-23 | Option Exercise | 2,000 | 52.27 | 104,540 | 2024-09-25 20:54:39 |
| LGND | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | 2024-09-20 | Sell | 1,275 | 103.94 | 132,518 | 2024-09-24 19:41:37 |
| LGND | LIGAND PHARMACEUTICALS INC | Korenberg Matthew E | President & COO | 2024-09-20 | Sell | 16,047 | 102.35 | 1,642,359 | 2024-09-24 19:41:15 |
| LGND | LIGAND PHARMACEUTICALS INC | Korenberg Matthew E | President & COO | 2024-09-20 | Option Exercise | 14,754 | 51.80 | 764,277 | 2024-09-24 19:41:15 |
| LGND | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | 2024-09-17 | Option Exercise | 1,486 | 79.63 | 118,328 | 2024-09-19 17:50:09 |
| LGND | LIGAND PHARMACEUTICALS INC | Korenberg Matthew E | President & COO | 2024-09-16 | Option Exercise | 5,774 | 58.49 | 337,696 | 2024-09-18 19:55:29 |
| LGND | LIGAND PHARMACEUTICALS INC | Korenberg Matthew E | President & COO | 2024-08-09 | Sell | 18,245 | 98.50 | 1,797,133 | 2024-08-13 17:21:14 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:52:17 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:52:17 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:52:17 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:52:17 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:52:17 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:52:17 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:52:17 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-08-08 | Buy | 2,500 | 97.39 | 243,481 | 2024-08-09 17:49:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Gray Nancy Ryan | Directior | 2024-05-09 | Sell | 934 | 83.20 | 77,713 | 2024-05-17 20:00:48 |
| LGND | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | 2024-05-15 | Sell | 13,293 | 86.26 | 1,146,704 | 2024-05-17 19:59:50 |
| LGND | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | 2024-05-15 | Option Exercise | 6,917 | 55.71 | 385,346 | 2024-05-17 19:59:50 |
| LGND | LIGAND PHARMACEUTICALS INC | Korenberg Matthew E | President & Chief Operating | 2024-05-13 | Sell | 17,598 | 84.99 | 1,495,741 | 2024-05-15 19:34:53 |
| LGND | LIGAND PHARMACEUTICALS INC | Reardon Andrew | Chief Legal Officer & | 2024-05-09 | Sell | 10,000 | 83.04 | 830,449 | 2024-05-13 17:32:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Reardon Andrew | Chief Legal Officer & | 2024-05-09 | Option Exercise | 10,000 | 52.27 | 522,700 | 2024-05-13 17:32:46 |
| LGND | LIGAND PHARMACEUTICALS INC | Aryeh Jason | Directior | 2024-04-30 | Option Exercise | 2,406 | 52.30 | 125,834 | 2024-05-02 18:07:17 |
| LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Directior | 2024-04-24 | Option Exercise | 2,893 | 39.35 | 113,840 | 2024-04-26 18:35:31 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | 2024-03-25 | Option Exercise | 16,015 | 57.39 | 919,147 | 2024-03-27 17:47:59 |
| LGND | LIGAND PHARMACEUTICALS INC | Sabba Stephen L | Directior | 2024-03-05 | Sell | 1,893 | 74.30 | 140,650 | 2024-03-07 13:27:20 |
| LGND | LIGAND PHARMACEUTICALS INC | Sabba Stephen L | Directior | 2024-03-05 | Option Exercise | 2,893 | 0.00 | 0 | 2024-03-07 13:27:20 |
| LGND | LIGAND PHARMACEUTICALS INC | Aryeh Jason | Directior | 2024-03-05 | Option Exercise | 2,893 | 39.35 | 113,840 | 2024-03-06 17:28:44 |
| LGND | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | 2024-02-27 | Sell | 140 | 88.46 | 12,384 | 2024-02-29 18:50:28 |
| LGND | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | 2024-02-27 | Option Exercise | 1,264 | 56.62 | 71,564 | 2024-02-29 18:50:28 |
| LGND | LIGAND PHARMACEUTICALS INC | Davis Todd C | CHIEF EXECUTIVE OFFICER | 2023-09-22 | Buy | 4,000 | 59.38 | 237,529 | 2023-09-25 16:44:43 |
| LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Directior | 2023-05-16 | Sell | 4,444 | 77.20 | 343,081 | 2023-05-18 17:18:57 |
| LGND | LIGAND PHARMACEUTICALS INC | Sabba Stephen L | Directior | 2023-05-10 | Sell | 6,408 | 77.13 | 494,225 | 2023-05-12 15:43:24 |
| LGND | LIGAND PHARMACEUTICALS INC | Sabba Stephen L | Directior | 2023-05-10 | Option Exercise | 6,408 | 0.00 | 0 | 2023-05-12 15:43:24 |
| LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Directior | 2023-05-08 | Sell | 6,408 | 76.56 | 490,628 | 2023-05-10 19:15:17 |
| LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Directior | 2023-05-08 | Option Exercise | 6,408 | 18.82 | 120,599 | 2023-05-10 19:15:17 |
| LGND | LIGAND PHARMACEUTICALS INC | Reardon Andrew | See Remarks | 2023-03-24 | Sell | 300 | 69.92 | 20,977 | 2023-03-28 17:00:13 |
| LGND | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | Directior | 2022-12-16 | Sell | 10,000 | 61.87 | 618,657 | 2022-12-20 18:36:56 |
| LGND | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | Directior | 2022-12-12 | Option Exercise | 20,000 | 12.78 | 255,600 | 2022-12-14 17:00:25 |
